Yotam Nisemblat

Yotam Nisemblat currently serves as the Chief Executive Officer at ProteKt Therapeutics since June 2023. Prior to this role, Yotam Nisemblat was the Director of Research Collaborations at Minovia Therapeutics from November 2021 to June 2023 and previously held the position of CEO at ProteKt Therapeutics Ltd. from March 2016 to November 2021. Yotam Nisemblat's earlier career at BioLineRx spanned from 2006 to March 2016, where various roles included Drug Development Director and Senior Drug Development Manager. Academic qualifications include an MBA in Finance from Reichman University, an MSc in Neurobiology with a focus on Alzheimer's Disease from Tel Aviv University, and a BSc in Biotechnology and Food Engineering from the Technion - Israel Institute of Technology.